Pin your most used calculators here by clicking the star in the dropdown.
IPS-7 (Adult Hodgkin Lymphoma)
Clinical Context & Background
The International Prognostic Score (IPS-7) remains a fundamental tool for baseline risk. In 2026, clinicians use this score to decide between ABVD and intensified regimens like BrECADD or N-AVD.
Primary Source EvidenceHasenclever D, et al. N Engl J Med. 1998;339(21):1506-1514.
Formula Logic
Sum of 7 independent risk factorsReference Data
| Score | Risk Group | Modern 5-Year PFS (Est.) |
|---|---|---|
| 0-1 | Low Risk | 92-96% |
| 2-3 | Intermediate Risk | 85-91% |
| ≥ 4 | High Risk | 75-84% |
Evidence-based oncology decision support. Verify with clinical guidelines.